000			03530nam a22003735i 4500
001			100763
003			ESmaUEC
005			20230102113010.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			180926s2018 gw | s |||| 0|eng d
020			_a9783319973678 _9
024	7		_a10.1007/978-3-319-97367-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
050		4	_aQR201.T6 2018 EB
245	1	0	_aUnderstanding the Host Immune Response Against Mycobacterium tuberculosis Infection _cedited by Vishwanath Venketaraman.
264		1	_aCham, Switzerland _bSpringer International Publishing _c2018
300			_a1 recurso en línea (X, 144 páginas 14 ilustraciones,12 ilustraciones a color)
336			_aTexto _btxt _2rdacontent
347			_atext file _bPDF _2
505	0		_a1. Co-Morbidities in HIV and Tuberculosis. Elizabeth Luke Hanna, Dept of Clinical Research, National institute for Research in TB, India -- 2. Diabetes and Tuberculosis. Blanca Restrepo, Dept. of Microbiology, Immunology, Molecular Genetics, UT Health - San Antonio -- 3. Extrapulmonary Tuberculosis. Johan Feuth Schoeman, Dept of Neurology, University of Stellenbosch -- 4. Animal Models to Study Adaptive Immune Responses Against M. tb Infection. Janice J. Endsley, Dept of Pathology, UT Medical Branch -- 5. Immunodiagnosis of Tuberculosis. Keertan Dheda, Dept of Respiratory Medicine, University of Cape Town -- 6. Granulomatous Responses Against M. tb Infection. Selvakumar Subbian, Dept of Biomedical and Health Sciences, Rutgers University -- 7. Host-Directed Therapies for Tuberculosis. Vishwanath Venketaraman (editor).
520	3		_aAccording to the World Health Organization, approximately one third of the world's population is latently infected with Mycobacterium tuberculosis (M. tb [LTBI]), of whom about 9 million have active tuberculosis (TB). It is estimated that approximately 2 million individuals die each year from active TB. An estimated 14.4% of these individuals have HIV and M. tb co-infection. TB has long been known to be one of the leading causes of death in HIV-infected individuals. Recent evidence now indicates that individuals with type 2 diabetes, the elderly, and chronic smokers are also increasingly susceptible to TB infection, the ability of their immune system to fight off active TB infection having been compromised by their condition. This book therefore aims to provide a detailed review of recent advances in the research that involves characterizing the host's immune responses against TB infection in conditions such as HIV, diabetes, chronic cigarette smoking and aging, and strategies to restore favorable immune responses against this deadly pathogen.
650		7	_aMycobacterium tuberculosis _9668821 _2embne
650		7	_aEnfermedades infecciosas _2embne _9138404
650		7	_aInmunología _2embne _9138330
700	1		_aVenketaraman, Vishwanath. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _0http://id.loc.gov/authorities/names/no2005046756 _1http://viaf.org/viaf/148105729 _9106996
776	0	8	_iEdición impresa: _z9783319973661
776	0	8	_iEdición impresa: _z9783319973685
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-97367-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
490	0		_aBiomedical and Life Sciences (Springer-11642)
942			_2lcc
998			_aSI _a_alco _a_vill _b04/2019 _cm _dz _ek _feng _ggw _h0
999			_c100763 _d100763 _x1